[Changes in methotrexate pharmacokinetics by inclusion in liposomes and the different effects on experimentally induced tumors].
Encapsulation of methotrexate in liposomes does not only alter--as is generally known--the pharmacokinetics of the drug, but reduces the growth of some experimentally induced tumors in rats.